Renal cell carcinoma associated with xp11.2 translocations, report of a case

Urology

Volumn 76, Issue 1, 2010, Pages 156-158

  Jing, Hong Biao ^a,b,c   Tai, Yanhong ^a,b,c   Xu, Dazhou ^a,b,c   Yang, Fan ^a,b,c   Geng, Ming ^a,b,c  

^a JINAN MILITARY GENERAL HOSPITAL   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c NANTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CHROMOSOME TRANSLOCATION; CHROMOSOME XP; COMPUTER ASSISTED TOMOGRAPHY; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; NEPHRECTOMY; PRIORITY JOURNAL; TUMOR VOLUME; URETER SURGERY; CHILD; GENE TRANSLOCATION; GENETICS; KIDNEY TUMOR;

CARCINOMA, RENAL CELL; CHILD; HUMANS; KIDNEY NEOPLASMS; MALE; TRANSLOCATION, GENETIC;

EID: 77955868838     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.07.1276     Document Type: Article

References (14)

1. Argani P, Ladanyi M. Renal carcinomas associated with Xp11.2 translocations/TFE3 gene fusions. In: Eble JN, Sauter G, Epstein JI, et al, eds. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs. Lyon, France:IARC;2004:37-38.
2. Argani P, Antonescu CR, Illei PB, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma. A distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol. 2001;159:179-192. (Pubitemid 33704203)
3. Argani P, Antonescu CR, Couturier J, et al. PRCC-TFE3 renal carcinomas. Morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X; 1) (p11.2; q21). Am J Surg Pathol. 2002;26:1553-1566. (Pubitemid 35387219)
4. Clark J, Lu YJ, Sidhar SK, et al. Fusion of splicing factor genes PSF and Non O (p54nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene. 1997;15:2233-2239. (Pubitemid 27493913)
5. Argani P, Lui MY, Couturier J, et al. Cloning of a novel CLTCTFE3 gene fusion in pediatric renal adenocarcinoma with t(X; 17)(p11.2;q23). Oncogene. 2003;22:5374-5378. (Pubitemid 37056101)
6. Argani P, Ladanyi M. Translocation carcinomas of the kidney. Clin Lab Med. 2005;25:363-378. (Pubitemid 40545824)
7. Salles PGO, Soto M Jr. Kidney carcinoma associated with Xp11.2 translocation/TFE3(ASPL-TFE3) gene fusion. Int Braz J Urol. 2005;31:251-255.
8. Suzigan S, Drut R, Faria P, et al. Xp11 translocation carcinoma of the kidney presenting with multilocular cystic renal cell carcinomalike features. Int J Surg Pathol. 2007;15(2):199-203.
9. Argani P, Lal P, Hutchinson B, et al. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: A sensitive and specific immunohistochemical assay. Am J Surg Pathol. 2003;27:750-761. (Pubitemid 36617511)
10. Meyer PN, Clark JI, Flanigan RC, et al. Xp11.2 translocation renal cell carcinoma with very aggressive course in five adult patients. Am J Clin Pathol. 2007;128:70-79. (Pubitemid 47121717)
11. Schinstine M, Filie AC, Torres-Cabala C, et al. Fine-needle aspiration of a Xp11.2 translocation/TFE3 fusion renal cell carcinoma metastatic to the lung: Report of a case and review of the literature. Diagn Cytopathol. 2006;34:751-756. (Pubitemid 44663251)
12. Armah HB, Parwani AV. Renal cell carcinoma in a 33-year-old male with an unusual morphology and an aggressive clinical course: Possible Xp11.2 translocation. Pathology. 2008;40:306-308. (Pubitemid 351563919)
13. Argani P, Laé M, Ballard ET, et al. Translocation carcinomas of the kidney after chemotherapy in childhood. J Clin Oncol. 2006;124: 1529-1534. (Pubitemid 46638774)
14. Rais-Bahrami S, Drabick JJ, De Marzo AM, et al. Xp11 translocation renal cell carcinoma: Delayed but massive and lethal metastases of a chemotherapy-associated secondary malignancy. Urology. 2007;70(1):178.e3-6.